Kinoshita M, Ikei N, Shin S, Inui S, Hirao T, Aono T
Otsuka Assay Laboratories, Otsuka Pharmaceutical Co., Ltd.
Nihon Gan Chiryo Gakkai Shi. 1990 Dec 20;25(12):2828-35.
The human papillomavirus detection and oncogenes amplifications were studied on DNAs from fifteen cervical cancers. We detected HPV16 and HPV18 using Southern blot hybridization and polymerase chain reaction (PCR) technique. The positive subjects of HPVs were eight cases (53%) observed by Southern blot hybridization and fourteen cases (93%) by PCR technique. The gene amplifications of oncogenes (c-myc and N-myc) were analysed by slot-blot method and were observed in c-myc but not in N-myc. The "LARGE" gene amplification (more than five fold) in c-myc was observed in one case (7%) and the "SMALL" gene amplifications (less than five fold) were observed in six cases (40%) in human cervical cancers. Although one of five cases (20%) with HPV16 was present c-myc gene amplification, all of three cases (100%) with HPV18 were found c-myc gene amplifications. In two out of three cases obtained more than three fold c-myc gene amplifications, HPV were not detectable. It is suggested that the negative correlation between gene amplification and numbers of HPV copies exist in advanced cervical cancers.
对15例宫颈癌的DNA进行了人乳头瘤病毒检测及癌基因扩增研究。我们采用Southern印迹杂交和聚合酶链反应(PCR)技术检测HPV16和HPV18。通过Southern印迹杂交观察到HPV阳性受试者有8例(53%),通过PCR技术观察到14例(93%)。采用狭缝印迹法分析癌基因(c-myc和N-myc)的基因扩增情况,结果显示在c-myc中观察到基因扩增,而在N-myc中未观察到。在1例(7%)人宫颈癌中观察到c-myc基因的“大”基因扩增(超过5倍),在6例(40%)中观察到“小”基因扩增(小于5倍)。虽然5例(20%)HPV16阳性病例中有1例存在c-myc基因扩增,但3例(100%)HPV18阳性病例均发现有c-myc基因扩增。在3例c-myc基因扩增超过3倍的病例中有2例未检测到HPV。提示在晚期宫颈癌中基因扩增与HPV拷贝数之间存在负相关。